Home/Filings/4/0000950170-24-139239
4//SEC Filing

Funtleyder Leslie D. 4

Accession 0000950170-24-139239

CIK 0001697532other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 8:30 PM ET

Size

8.4 KB

Accession

0000950170-24-139239

Insider Transaction Report

Form 4
Period: 2024-12-19
Funtleyder Leslie D.
DirectorChief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-12-19+150,000150,000 total
    Exercise: $1.02Exp: 2034-12-19Common Stock (150,000 underlying)
  • Award

    Common Stock

    2024-12-19+150,000427,911 total
Footnotes (2)
  • [F1]Consists of compensatory Restricted Stock Units ("RSUs") granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan") in connection with the Reporting Person's service as interim Chief Executive Officer. Each compensatory RSU represents a contingent right to receive one share of the issuer's common stock. The compensatory RSUs will vest in equal monthly installments over the 12-month period following the grant date, subject to the Reporting Person continuing to provide services through each such vesting date, provided that any outstanding and unvested RSUs will vest immediately upon the earlier to occur of (i) the approval by the United States Food and Drug Administration of the issuer's proposed new drug application relating to the treatment of Sorbitol Dehydrogenase or (ii) a Change in Control (as defined in the Plan).
  • [F2]Consists of Options granted under the Plan in connection with the Reporting Person's service as interim Chief Executive Officer. The Options will vest in equal monthly installments over the 12-month period following the grant date, subject to the Reporting Person continuing to provide services through each such vesting date, provided that any outstanding and unvested Options will vest immediately upon the earlier to occur of (i) the approval by the United States Food and Drug Administration of the issuer's proposed new drug application relating to the treatment of Sorbitol Dehydrogenase or (ii) a Change in Control (as defined in the Plan).

Documents

1 file

Issuer

Applied Therapeutics, Inc.

CIK 0001697532

Entity typeother

Related Parties

1
  • filerCIK 0001775394

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 8:30 PM ET
Size
8.4 KB